Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydrogen proton relaxation enhancement refers to the process by which the relaxation rates of hydrogen nuclei (protons), particularly those in water molecules, are increased—typically through interactions with paramagnetic agents or changes in their molecular environment. This phenomenon is central to magnetic resonance imaging (MRI) and nuclear magnetic resonance (NMR) spectroscopy, as it directly affects image contrast and signal intensity. It is not a direct drug target, but is a phenomenon exploited by MRI contrast agents to improve visualization of tissues.
Increased local field fluctuations from paramagnetic agents or changes in molecular environment accelerate spin-lattice (T1) and spin-spin (T2) relaxation of hydrogen protons, primarily in water.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrogen Proton Relaxation Enhancement (None).